Author

Øystein Sefland

Haukeland University HospitalORCID 0000-0002-7176-7597Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Organism:human· 1 Research Focus:perturbation response prediction· 1

Frequent Co-Authors

Bjørn Tore GjertseniD· 1 shared Dominik Georg Friedrich WolfiD· 1 shared Erin Craig· 1 shared Henrik Hjorth‐HanseniD· 1 shared Jesper StentoftiD· 1 shared Johan RichteriD· 1 shared Mathias BrevikiD· 1 shared Monica HellesøyiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Bjørn Tore GjertsenORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Deep single-cell immune and signaling profiles predict long term therapy response in chronic myeloid leukemia within hours

Stein‐Erik Gullaksen, Mathias Brevik, Øystein Sefland, Erin Craig, Monica Hellesøy, Ulla Olsson‐Strömberg, Jesper Stentoft, Johan Richter, Tobias Gedde‐Dahl, Robert John Tibshirani, Sylvia K. Plevritis, Dominik Georg Friedrich Wolf, Satu M. Mustjoki, Henrik Hjorth‐Hansen, Bjørn Tore Gjertsen

The paper uses mass cytometry to analyze immune and signaling profiles in CML patients within hours of TKI treatment to predict 12-month treatment response.

bioRxiv · Nov 10, 2025 · PreprintCancer Biology